停止性别肯定激素治疗后跨性别女性的精子发生恢复。
The return of spermatogenesis in transgender women ceasing gender-affirming hormone therapy.
机构信息
Mount Sinai Center for Transgender Medicine and Surgery, New York, NY, USA; Division of Pediatric Endocrinology, Mount Sinai Kravis Children's Hospital, New York, NY, USA.
Mount Sinai Center for Transgender Medicine and Surgery, New York, NY, USA; Division of Endocrinology, Mount Sinai Health System and Icahn School of Medicine at Mount Sinai, New York, NY, USA.
出版信息
Cell Rep Med. 2023 Jan 17;4(1):100835. doi: 10.1016/j.xcrm.2022.100835.
Abstract
Fertility has become a priority in transgender health research. In this issue of Cell Reports Medicine, a study by de Nie et al. of nine transgender women demonstrates sperm production after the cessation of gender-affirming hormone therapy (GAHT). Their results suggest the transient nature of gonadal suppression by GAHT.
摘要
生育能力已成为 transgender 健康研究的重点。在本期《Cell Reports Medicine》中，de Nie 等人的一项研究表明，九名 transgender 女性在停止性别肯定激素治疗（GAHT）后仍能产生精子。他们的研究结果表明，GAHT 对性腺的抑制作用是暂时的。
相似文献
1
The return of spermatogenesis in transgender women ceasing gender-affirming hormone therapy.
Cell Rep Med. 2023 Jan 17;4(1):100835. doi: 10.1016/j.xcrm.2022.100835.
2
Successful restoration of spermatogenesis following gender-affirming hormone therapy in transgender women.
Cell Rep Med. 2023 Jan 17;4(1):100858. doi: 10.1016/j.xcrm.2022.100858.
3
Sperm quality in transgender women before or after gender affirming hormone therapy-A prospective cohort study.
Andrology. 2021 Nov;9(6):1773-1780. doi: 10.1111/andr.12999. Epub 2021 Mar 23.
4
Reproductive functions and fertility preservation in transgender women: a French case series.
Reprod Biomed Online. 2021 Aug;43(2):339-345. doi: 10.1016/j.rbmo.2021.04.016. Epub 2021 Apr 30.
5
Which U.S. States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services.
J Sex Med. 2021 Feb;18(2):410-422. doi: 10.1016/j.jsxm.2020.11.016. Epub 2021 Jan 7.
6
New Insights Into Extended Steroid Hormone Profiles in Transwomen in a Multi-Center Setting in Germany.
J Sex Med. 2021 Oct;18(10):1807-1817. doi: 10.1016/j.jsxm.2021.08.004.
7
Fertility preservation options for transgender and gender-nonconforming individuals.
Curr Opin Obstet Gynecol. 2019 Jun;31(3):170-176. doi: 10.1097/GCO.0000000000000537.
8
Histological study on the influence of puberty suppression and hormonal treatment on developing germ cells in transgender women.
Hum Reprod. 2022 Jan 28;37(2):297-308. doi: 10.1093/humrep/deab240.
9
Sex hormones, insomnia, and sleep quality: Subjective sleep in the first year of hormone use in transgender persons.
Sleep Med. 2023 Jul;107:316-326. doi: 10.1016/j.sleep.2023.04.028. Epub 2023 May 20.
10
The Effect of Gender-Affirming Hormone Therapy on the Risk of Subclinical Atherosclerosis in the Transgender Population: A Systematic Review.
Endocr Pract. 2023 Jun;29(6):498-507. doi: 10.1016/j.eprac.2022.12.017. Epub 2023 Jan 2.
本文引用的文献
1
Successful restoration of spermatogenesis following gender-affirming hormone therapy in transgender women.
Cell Rep Med. 2023 Jan 17;4(1):100858. doi: 10.1016/j.xcrm.2022.100858.
2
Changes in Serum Testosterone and Adrenal Androgen Levels in Transgender Women With and Without Gonadectomy.
J Clin Endocrinol Metab. 2023 Jan 17;108(2):331-338. doi: 10.1210/clinem/dgac576.
3
A cohort study on factors impairing semen quality in transgender women.
Am J Obstet Gynecol. 2022 Mar;226(3):390.e1-390.e10. doi: 10.1016/j.ajog.2021.10.020. Epub 2021 Oct 22.
4
Adolescent Transgender Females Present Impaired Semen Quality That Is Suitable for Intracytoplasmic Sperm Injection Even Before Initiating Gender-Affirming Hormone Treatment.
Reprod Sci. 2022 Jan;29(1):260-269. doi: 10.1007/s43032-021-00561-y. Epub 2021 Mar 31.
5
Sperm quality in transgender women before or after gender affirming hormone therapy-A prospective cohort study.
Andrology. 2021 Nov;9(6):1773-1780. doi: 10.1111/andr.12999. Epub 2021 Mar 23.
6
Characterisation of testicular function and spermatogenesis in transgender women.
Hum Reprod. 2021 Jan 1;36(1):5-15. doi: 10.1093/humrep/deaa254.
7
Impaired semen quality in trans women: prevalence and determinants.
Hum Reprod. 2020 Jul 1;35(7):1529-1536. doi: 10.1093/humrep/deaa133.
8
Effects of Estrogen on Spermatogenesis in Transgender Women.
Urology. 2019 Oct;132:117-122. doi: 10.1016/j.urology.2019.06.034. Epub 2019 Jul 13.
9
ENDOCRINE TREATMENT OF GENDER-DYSPHORIC/GENDER-INCONGRUENT PERSONS: AN ENDOCRINE SOCIETY CLINICAL PRACTICE GUIDELINE.
Endocr Pract. 2017 Dec;23(12):1437. doi: 10.4158/1934-2403-23.12.1437.
10
Male contraception.
Endocr Rev. 2002 Dec;23(6):735-62. doi: 10.1210/er.2002-0002.
Zotero 插件